{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:55:28Z","timestamp":1791107728524,"version":"4.1.0"},"reference-count":47,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,4,7]],"date-time":"2008-04-07T00:00:00Z","timestamp":1207526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\/Aims: <\/jats:bold> Recent studies using transgenic mouse models have demonstrated that the presence of hepatitis C virus (HCV) singularly induces insulin resistance (IR). When evaluated in humans, the exclusion of other factors influencing IR, such as obesity, alcohol intake, hepatic inflammation and steatosis is needed, but only few studies have been performed to these ends. Therefore, we aimed at exploring the singular effects of HCV on glucose metabolism through analysis of HCV carriers with persistently normal serum aminotransferase.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> Non\u2010obese, non\u2010diabetic and non\u2010alcoholic HCV carriers (<jats:italic>n<\/jats:italic>=30) were enrolled with 30 hepatitis B virus carriers matched by age, gender, body mass index and waist\u2010to\u2010hip ratio. All patients maintained normal serum aminotransferase (&lt;30\u2003U\/L), hyaluronic acid (&lt;50\u2003ng\/ml) and platelet count (&gt;150 \u00d7 10<jats:sup>3<\/jats:sup>\/\u03bcl) for more than 5 years without additional treatments, and had no signs of steatosis. We then compared fasting plasma glucose, serum insulin and adiponectin, and homoeostasis model assessment of IR (HOMA\u2010IR) and HOMA\u2010\u03b2 indices between the groups.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> There were no significant differences in IR\/secretion\u2010associated markers or serum adiponectin. Multivariate analysis demonstrated that the presence of HCV was not an independent predictor of IR. HOMA\u2010IR was strongly correlated with waist circumferences and serum \u03b3\u2010glutamyltransferase in HCV carriers, but not with serum aminotransferase, high\u2010sensitivity C\u2010reactive protein, hyaluronic acid or HCV core antigen.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> These results suggest that the presence of HCV alone does not affect IR. Coexistence of hepatitis, steatosis and\/or fibrosis may be important to the pathogenesis of IR induced by chronic HCV infection.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2008.01737.x","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T11:09:24Z","timestamp":1281092964000},"page":"1104-1111","source":"Crossref","is-referenced-by-count":19,"title":["Insulin resistance and hepatitis C virus: a case\u2013control study of non\u2010obese, non\u2010alcoholic and non\u2010steatotic hepatitis virus carriers with persistently normal serum aminotransferase"],"prefix":"10.1111","volume":"28","author":[{"given":"Naoki","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadanobu","family":"Nagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiharu","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goro","family":"Tsuruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruaki","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeji","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Ichijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaname","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendo","family":"Kiyosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,8,6]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80631-2"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290235"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-8-200010170-00009"},{"key":"e_1_2_7_5_2","first-page":"514","article-title":"Insulin resistance and HCV","volume":"45","author":"Negro F.","year":"2006","journal-title":"will new knowledge modify clinical management?"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01338.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01443.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2003.00841.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2007.00152.x"},{"key":"e_1_2_7_10_2","first-page":"601","article-title":"Phlebotomy","volume":"39","author":"Tanaka N","year":"2004","journal-title":"a promising treatment for chronic hepatitis C"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00835.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840140117"},{"key":"e_1_2_7_13_2","first-page":"1715","article-title":"Glucose disposal, beta\u2010cell secretion, and hepatic insulin extraction in cirrhosis","volume":"99","author":"Marchesini G","year":"1990","journal-title":"a minimal model assessment"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.08.032"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63408-6"},{"key":"e_1_2_7_16_2","first-page":"840","article-title":"Hepatitis C virus infection and diabetes","volume":"126","author":"Shintani Y","year":"2004","journal-title":"direct involvement of the virus in the development of insulin resistance"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01038.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.059"},{"key":"e_1_2_7_19_2","first-page":"2191","article-title":"Abnormal lipid and glucose metabolism in obesity","volume":"132","author":"Parekh S","year":"2007","journal-title":"implications for nonalcoholic fatty liver disease"},{"key":"e_1_2_7_20_2","first-page":"1096","article-title":"Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients","volume":"29","author":"Lecube A","year":"2006","journal-title":"a case\u2013control study"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.04.008"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113428"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01198.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.5551\/jat.13.202"},{"key":"e_1_2_7_25_2","first-page":"83","article-title":"Incidence of insulin resistance in obese subjects in a rural Japanese population","volume":"7","author":"Ohnishi H","year":"2005","journal-title":"the Tanno and Sobetsu study"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50346"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01355.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31815591aa"},{"key":"e_1_2_7_29_2","first-page":"49","article-title":"Efficacy and safety of 6\u2010month iron reduction therapy in patients with hepatitis C virus\u2010related cirrhosis","volume":"42","author":"Tanaka N","year":"2007","journal-title":"a pilot study"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6346(02)00309-1"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2001.210501.x"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608537103"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.66.987"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1995.tb00462.x"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.19.3.287"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-5926-4-6"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1427"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.5.732"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2002.5288"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01683-06"},{"key":"e_1_2_7_41_2","first-page":"683","article-title":"PPAR\u03b1 activation is essential for HCV core protein\u2010induced hepatic steatosis and hepatocellular carcinoma in mice","volume":"118","author":"Tanaka N","year":"2008","journal-title":"J Clin Invest"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.02.044"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.05.030"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21703"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.12.049"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01402.x"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.10.5678"},{"key":"e_1_2_7_48_2","first-page":"441","article-title":"Effects of bezafibrate in patients with chronic hepatitis C virus infection","volume":"13","author":"Fujita N","year":"2006","journal-title":"combination with interferon and ribavirin"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2008.01737.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2008.01737.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T15:07:23Z","timestamp":1697296043000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2008.01737.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,6]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1478-3231.2008.01737.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01737.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,6]]}}}